Not applicableUnknownNCT05788835What this trial is testingDEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled TrialWho this might be right forHCC Xuhua Duan 220
Testing effectiveness (Phase 2)Study completedNCT05040438What this trial is testingNatural Killer (NK) Cell Therapy in Locally Advanced HCCWho this might be right forLocally Advanced Hepatocellular Carcinoma Vaxcell Bio, Co., Ltd. 17
Not applicableUnknownNCT05889325What this trial is testingTo Evaluate the Performance of HepaSphere Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy on Unresectable Colorectal Liver MetastasesWho this might be right forColorectal Liver Metastases (CRCLM) Peking University Cancer Hospital & Institute 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684040What this trial is testingCombination Therapy in Patients With Resectable Liver CancerWho this might be right forLiver Cancer (Primary and Metastatic) Affiliated Hospital of Guangdong Medical University 68
Large-scale testing (Phase 3)UnknownNCT03780049What this trial is testingHAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-BWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 304
Large-scale testing (Phase 3)Looking for participantsNCT06492395What this trial is testingLenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTTWho this might be right forHepatocellular Carcinoma Non-resectable Second Affiliated Hospital of Guangzhou Medical University 178
Testing effectiveness (Phase 2)UnknownNCT04135690What this trial is testingHAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized TrialWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT05348811What this trial is testingHAIC Combined With Donafenib and Sintilimab for Unresectable ICCWho this might be right forCholangiocarcinoma Zhongda Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT07560488What this trial is testingIpilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular CarcinomaWho this might be right forHCC - Hepatocellular CarcinomaConversion Therapy Tianjin Medical University Cancer Institute and Hospital 43
Testing effectiveness (Phase 2)Looking for participantsNCT07337460What this trial is testingEfficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence FactorsWho this might be right forHepatocellular Carcinoma (HCC) Northern Jiangsu People's Hospital 30
Early research (Phase 1)UnknownNCT06283303What this trial is testingA Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal CancerWho this might be right forColorectal Cancer Metastatic China Medical University, China 8
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Testing effectiveness (Phase 2)UnknownNCT05877001What this trial is testingThe Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver MetastasesWho this might be right forColorectal Liver Metastases Peking University Cancer Hospital & Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT05220722What this trial is testingPressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver TumorsWho this might be right forHepatocellular CarcinomaIntrahepatic Cholangiocarcinoma TriSalus Life Sciences, Inc. 23
Early research (Phase 1)Study completedNCT00732836What this trial is testingHepatic Arterial Infusion (HAI) of AbraxaneWho this might be right forLiver CancerAdvanced CancersSolid Tumors M.D. Anderson Cancer Center 64
Post-approval studies (Phase 4)Not Yet RecruitingNCT07790419What this trial is testingA Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular InvasionWho this might be right forLiver Cancer Zhai Wenlong 40
Testing effectiveness (Phase 2)Study completedNCT05532319What this trial is testingHAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCCWho this might be right forLiver Cancer Guangxi Medical University 64
Testing effectiveness (Phase 2)UnknownNCT05821361What this trial is testingHAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular CarcinomaWho this might be right forUnrescetable Hepatocellular Carcinoma Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT00035919What this trial is testingSafety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to LiverWho this might be right forColorectal Neoplasms University of Southern California
Large-scale testing (Phase 3)Study completedNCT00324727What this trial is testingHepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin)Metastatic Cancer Delcath Systems Inc. 93